Premature Puberty and Thimerosal-Containing Hepatitis B Vaccination: A Case-Control Study in the Vaccine Safety Datalink
Studies suggest a relationship between exposure to endocrine disrupters, such as mercury (Hg), and premature puberty. Hg exposure from Thimerosal-containing hepatitis B vaccine, administered at specific intervals within the first six months of life, and the child’s long-term risk of being...
Main Authors: | David A. Geier, Janet K. Kern, Mark R. Geier |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-11-01
|
Series: | Toxics |
Subjects: | |
Online Access: | https://www.mdpi.com/2305-6304/6/4/67 |
Similar Items
-
Thioredoxin Reductase Inhibitors as Potential Antitumors: Mercury Compounds Efficacy in Glioma Cells
by: Vanessa Pires, et al.
Published: (2022-06-01) -
Comparative evaluation of phenol and thimerosal as preservatives for a candidate vaccine against American cutaneous leishmaniasis
by: Wilson Mayrink, et al.
Published: (2010-02-01) -
Determination of thiomersal and mercurial residues by photo-degradation and flow injection analysis with luminescence probing using carbon quantum dots prepared from thiourea
by: Claudiomar R. Franco, et al.
Published: (2023-08-01) -
Frequency of different types of precocious puberty, determining the predisposing factor and need to treatment in children - Emam Hospital (1993-2000)
by: Moayeri H, et al.
Published: (2002-07-01) -
Evaluation of clinical and laboratory findings in the differential diagnosis of central precocious puberty and premature thelarche
by: Aslı Beştaş, et al.
Published: (2023-01-01)